NCT01624493 BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients Status WITHDRAWN Phase PHASE1/PHASE2
NCT01622660 Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy Status TERMINATED Phase PHASE2
NCT01621243 M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01610206 A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01608711 A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 Status COMPLETED Phase PHASE2
NCT01606748 A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin Status COMPLETED Phase PHASE2
NCT01593228 Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial Status COMPLETED Phase PHASE3
NCT01586611 A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer Status UNKNOWN Phase PHASE3
NCT01585805 Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01574716 Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation Status COMPLETED Phase PHASE2
NCT01564251 A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT01560949 Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE2
NCT01554410 Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma Status COMPLETED Phase PHASE1
NCT01553019 Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01532687 Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma Status COMPLETED Phase PHASE2
NCT01531712 Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable Status TERMINATED Phase PHASE2
NCT01526135 Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE3
NCT01525069 Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma Status TERMINATED Phase PHASE1
NCT01524991 First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma Status COMPLETED Phase PHASE2
NCT01509911 A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment Status UNKNOWN Phase PHASE2